Clinical trial
Effect Of Dutasteride On Intraprostatic Dihydrotestosterone (DHT) Levels
NCT00062790 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00062790 |
|---|---|
| Title | Effect Of Dutasteride On Intraprostatic Dihydrotestosterone (DHT) Levels |
| Official title | Effects of Dutasteride on Intraprostatic Dihydrotestosterone (DHT) Levels |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Prostatic Hyperplasia |
| Intervention type | Drug |
| Interventions | Dutasteride |
| Enrollment | 50 |
| Start date | Oct 1, 2003 |
| Completion | Jul 1, 2005 |
| First posted | Jun 17, 2003 |
| Last update posted | Sep 15, 2016 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: